- Home
- JAZZ vs ADT Comparison
JAZZ vs ADT Comparison
Compare JAZZ & ADT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- ADT
- Stock Information
- Founded
- JAZZ 2003
- ADT 1874
- Country
- JAZZ Ireland
- ADT United States
- Employees
- JAZZ N/A
- ADT N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- ADT Diversified Commercial Services
- Sector
- JAZZ Health Care
- ADT Consumer Discretionary
- Exchange
- JAZZ Nasdaq
- ADT Nasdaq
- Market Cap
- JAZZ 6.7B
- ADT 7.0B
- IPO Year
- JAZZ 2007
- ADT 2018
- Fundamental
- Price
- JAZZ $110.27
- ADT $8.54
- Analyst Decision
- JAZZ Strong Buy
- ADT Buy
- Analyst Count
- JAZZ 12
- ADT 4
- Target Price
- JAZZ $183.08
- ADT $9.05
- AVG Volume (30 Days)
- JAZZ 651.1K
- ADT 14.8M
- Earning Date
- JAZZ 07-30-2025
- ADT 07-24-2025
- Dividend Yield
- JAZZ N/A
- ADT 2.58%
- EPS Growth
- JAZZ 49.21
- ADT N/A
- EPS
- JAZZ 7.51
- ADT 0.59
- Revenue
- JAZZ $4,064,808,000.00
- ADT $4,976,265,000.00
- Revenue This Year
- JAZZ $6.05
- ADT $5.95
- Revenue Next Year
- JAZZ $4.68
- ADT $4.34
- P/E Ratio
- JAZZ $14.72
- ADT $14.43
- Revenue Growth
- JAZZ 5.76
- ADT 5.65
- 52 Week Low
- JAZZ $95.49
- ADT $6.53
- 52 Week High
- JAZZ $148.06
- ADT $8.72
- Technical
- Relative Strength Index (RSI)
- JAZZ 52.75
- ADT 55.88
- Support Level
- JAZZ $109.27
- ADT $8.35
- Resistance Level
- JAZZ $112.70
- ADT $8.53
- Average True Range (ATR)
- JAZZ 2.72
- ADT 0.13
- MACD
- JAZZ 0.42
- ADT 0.02
- Stochastic Oscillator
- JAZZ 67.81
- ADT 79.55
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About ADT ADT Inc.
ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name. The company segments include Consumer and Small Business (CSB).